Where does Waksmed Life Science rank among its competitors?

Waksmed Life Science ranks 1770th amongst 1895 active competitors, of which 98 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Waksmed Life Science?

Waksmed Life Science's top competitors include AbbVie, Gilead and Amgen. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Waksmed Life Science - 2026 Company Profile & Competitors

Company Details

Manufacturer of pharmaceutical products, ensuring quality and international standards compliance. The company focuses on delivering products with the best possible reputation. Human resources are considered essential to the company's operations. They provide a work-friendly atmosphere for skill development. The company aims to be a leading pharma company worldwide.

Website: www.waksmedlifescience.com/
Registered Address: Second Floor, No.57, 13th Cross, Novel Business Park, Anepalya, Hosur Roa, d, Bangalore, Bangalore, Karnataka, India, 560047

Key Metrics

Stage

Unfunded

Ranked

1770^th among 1895 active competitors

Similar Companies

AbbVie & 1923 more

View Waksmed Life Science's full profile

Waksmed Life Science is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
WAKSMED LIFESCIENCE PRIVATE LIMITED CIN: U51109KA2012PTC064577 , India, Active	Jun 26, 2012	₹10 - ₹50 Cr (As on Mar 31, 2025)	70 (As on Feb 29, 2024)

Waksmed Life Science has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Waksmed Life Science include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Waksmed Life Science, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 9 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	71/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	68/100
1770th	Waksmed Life Science Unfunded	Manufacturer of pharmaceutical products, ensuring quality and international standards compliance	-	-	16/100